ATE383893T1 - Verwendung von oligosacchariden zur stimulierung der produktion von beta-endorphin - Google Patents

Verwendung von oligosacchariden zur stimulierung der produktion von beta-endorphin

Info

Publication number
ATE383893T1
ATE383893T1 AT01953195T AT01953195T ATE383893T1 AT E383893 T1 ATE383893 T1 AT E383893T1 AT 01953195 T AT01953195 T AT 01953195T AT 01953195 T AT01953195 T AT 01953195T AT E383893 T1 ATE383893 T1 AT E383893T1
Authority
AT
Austria
Prior art keywords
oligosaccharide
oligosaccharides
endorphin production
skin
stimulate beta
Prior art date
Application number
AT01953195T
Other languages
English (en)
Inventor
Frederic Bonte
Marc Dumas
Stephane Lhermite
Alex Saunois
Original Assignee
Lvmh Rech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvmh Rech filed Critical Lvmh Rech
Application granted granted Critical
Publication of ATE383893T1 publication Critical patent/ATE383893T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9771—Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01953195T 2000-07-07 2001-07-05 Verwendung von oligosacchariden zur stimulierung der produktion von beta-endorphin ATE383893T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0008879A FR2811228B1 (fr) 2000-07-07 2000-07-07 Utilisation d'oligosaccharides ou d'extraits de plantes en contenant comme agent cosmetique ou dermatologique notamment pour stimuler la production de beta-endorphine dans la peau

Publications (1)

Publication Number Publication Date
ATE383893T1 true ATE383893T1 (de) 2008-02-15

Family

ID=8852235

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01953195T ATE383893T1 (de) 2000-07-07 2001-07-05 Verwendung von oligosacchariden zur stimulierung der produktion von beta-endorphin

Country Status (10)

Country Link
US (2) US20030157200A1 (de)
EP (2) EP1299081B9 (de)
JP (1) JP2004502713A (de)
KR (1) KR100793912B1 (de)
CN (2) CN1440276A (de)
AT (1) ATE383893T1 (de)
AU (1) AU2001275694A1 (de)
DE (1) DE60124715T2 (de)
FR (1) FR2811228B1 (de)
WO (1) WO2002003945A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4178829B2 (ja) * 2002-05-02 2008-11-12 株式会社Ｊ−オイルミルズ 抗アレルギー性組成物
US20060234980A1 (en) * 2002-05-31 2006-10-19 Hiroyuki Hashimoto Antiinflammatory agent, agent for preventing/ameliorating allergic diseases and functional food
EP1631594A1 (de) * 2003-02-04 2006-03-08 Solabia (SA) Neuer wirkstoff zur stimulation der befreiung der beta-endorphine, kosmetische und/oder dermatologische zusammensetzungen die ihn enthalten und deren verwendungen
FR2857873B1 (fr) * 2003-07-21 2006-02-24 Courtage Et De Diffusion Codif Procede et produit cosmetique destines a limiter la croissance des tissus adipeux
FR2857874A1 (fr) * 2003-07-21 2005-01-28 Courtage Et De Diffusion Codif Utilisation dans des produits cosmetiques de principes actifs en vue de reguler la proliferation et la differenciation des keratinocytes de l'epiderme
EP1529532A1 (de) * 2003-11-07 2005-05-11 Kabushiki Kaisha Honen Corporation Stachyose enthaltende antiallergische Zusammensetzung
JP2005179224A (ja) * 2003-12-18 2005-07-07 Noevir Co Ltd 皮膚外用剤
FR2868307B1 (fr) * 2004-04-01 2008-03-14 Courtage Et De Diffusion Codif Utilisation de beta-endorphine pour le traitement des rides
FR2868703B1 (fr) * 2004-04-08 2008-06-13 Expanscience Sa Lab Extrait total de lupin constitue d'un extrait de sucres de lupin et d'un extrait peptidique de lupin, procede d'obtention et utilisation
JP5207664B2 (ja) * 2007-06-04 2013-06-12 株式会社シャネル化粧品技術開発研究所 化粧品
KR101098581B1 (ko) * 2009-01-09 2011-12-26 서울대학교산학협력단 Ａｂｈ 항원을 이용한 염증질환 개선용 조성물
KR102275055B1 (ko) * 2014-04-30 2021-07-08 (주)아모레퍼시픽 알피나 골무꽃 추출물을 포함하는 조성물
EP3435765A1 (de) 2016-03-31 2019-02-06 Gojo Industries, Inc. Desinfektionszusammensetzung zur stimulation von antimikrobiellen peptiden
US10806769B2 (en) 2016-03-31 2020-10-20 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
JP2019510036A (ja) 2016-03-31 2019-04-11 ゴジョ・インダストリーズ・インコーポレイテッド プロバイオティクス／プレバイオティクス有効成分を含む清浄剤組成物
US11564879B2 (en) 2016-11-23 2023-01-31 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
US10383809B2 (en) * 2017-01-13 2019-08-20 Galactic Beauty, LLC Skin treatment compositions, masks and related methods
JP7274720B2 (ja) * 2018-09-26 2023-05-17 株式会社クラブコスメチックス エストロゲン受容体発現促進剤および細胞増殖促進剤
KR102282246B1 (ko) * 2020-10-27 2021-07-27 쿼럼바이오 주식회사 갈락토스를 함유하는 아토피 피부염의 예방, 개선, 또는 치료용 조성물
CN113662982A (zh) * 2021-09-24 2021-11-19 杭州配方师科技有限公司 一种灰毛豆籽和玫瑰茄花的提取物、提取方法及用途
CN113712869B (zh) * 2021-09-24 2023-08-18 杭州配方师科技有限公司 一种含灰毛豆籽和玫瑰茄花复合提取物的精华液及其制备方法
FR3143372A1 (fr) 2022-12-20 2024-06-21 C F E B Sisley Composition neurocosmetique pour prevenir les effets du stress
CN117357421A (zh) * 2023-10-25 2024-01-09 华熙生物科技股份有限公司 含有麦角硫因与二肽-1或其衍生物的皮肤外用组合物及其用途
WO2026000229A1 (en) * 2024-06-26 2026-01-02 L'oreal Composition for caring for the hair and/or the scalp
WO2026000226A1 (en) * 2024-06-26 2026-01-02 L'oreal Composition for caring for keratin materials
WO2026000228A1 (en) * 2024-06-26 2026-01-02 L'oreal Composition for cleansing and/or caring for keratin materials
CN119074607B (zh) * 2024-08-29 2025-08-12 诺德溯源(广州)生物科技有限公司 适用于敏感肌的甘草植物防晒组合物及其制备方法
CN119104707A (zh) * 2024-09-20 2024-12-10 广东迪美新材料科技有限公司 一种体外评估化妆品原料及成品神经美容功效的方法
CN119235714A (zh) * 2024-09-26 2025-01-03 诺德溯源(广州)生物科技有限公司 一种调理痘敏肌的消炎祛痘组合物及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59176203A (ja) * 1983-03-28 1984-10-05 Kanebo Ltd 皮膚化粧料
LU84979A1 (fr) * 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
DE69332818T3 (de) * 1992-07-13 2008-01-24 Shiseido Co. Ltd. Zusammensetzung für dermatologische zubereitung
FR2708198B1 (fr) * 1993-07-28 1995-10-20 Dior Christian Parfums Composition cosmétique ou pharmaceutique, notamment dermatologique contenant un extrait de Tephrosia, en particulier Tephrosia purpurea.
FR2709061B1 (fr) * 1993-08-17 1996-07-19 Ladislas Robert Utilisation d'oligosaccharides dans la prévention et le traitement du vieillissement des tissus.
JP3963972B2 (ja) * 1995-11-17 2007-08-22 三省製薬株式会社 皮膚外用剤
FR2762783B1 (fr) * 1997-05-02 2002-09-13 Roc Sa Utilisation d'oligosaccharides pour le traitement du tissu conjonctif et methode de traitement cosmetique mettant en oeuvre ces oligosaccharides
US6030620A (en) * 1997-07-25 2000-02-29 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Skin care compositions containing an organic extract of chick pea
MXPA02004933A (es) * 1999-11-16 2004-08-12 Unilever Nv Composiciones cosmeticas conteniendo extracto de garbanzo y retinoides.

Also Published As

Publication number Publication date
EP1299081B1 (de) 2008-01-16
EP1911494A2 (de) 2008-04-16
US20080020073A1 (en) 2008-01-24
WO2002003945A1 (fr) 2002-01-17
CN101444470B (zh) 2011-10-05
FR2811228B1 (fr) 2002-10-25
CN1440276A (zh) 2003-09-03
CN101444470A (zh) 2009-06-03
AU2001275694A1 (en) 2002-01-21
KR100793912B1 (ko) 2008-01-15
DE60124715D1 (de) 2007-01-04
US20030157200A1 (en) 2003-08-21
JP2004502713A (ja) 2004-01-29
EP1911494A3 (de) 2008-07-02
DE60124715T2 (de) 2008-11-06
EP1299081A1 (de) 2003-04-09
FR2811228A1 (fr) 2002-01-11
EP1299081B9 (de) 2009-03-11
KR20030062238A (ko) 2003-07-23

Similar Documents

Publication Publication Date Title
DE60124715D1 (de) Er produktion von beta-endorphin
AU2001253038A1 (en) Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
AUPQ878600A0 (en) Compositions and methods for the treatment of intact skin
ATE80790T1 (de) Zusammensetzung zur behandlung der haut.
ITRM960799A0 (it) Uso di batteri lattici per accrescere il livello delle ceramidi della pelle e della mucosa, e composizioni dermatologiche e cosmetiche atte
ES2127490T3 (es) Utilizacion de un aceite rico en acido petroselenico como agente hidratante.
ZA200204157B (en) Echinacea extract as anti-irritant and anti-aging booster in cosmetic compositions.
ATE77230T1 (de) Melatoninhaltige mittel sowie deren verwendungen.
DK1689356T3 (da) Topiske sammensætninger med natriumhyaluronatfragmenter og et retinoid
ATE260639T1 (de) Sialylzucker und ihre derivaten enthaltende topische zubereitungen
EP1465577A4 (de) Verfahren zur verbesserung des erscheinungsbildes der haut
IL138290A0 (en) Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
BG101126A (en) The use of muramylpeptide compounds
MXPA03011622A (es) Uso de glicoproteina para el tratamiento y re-epitelizacion de heridas.
FR2782922B1 (fr) Composition contenant de l'uree et ses utilisations dans le domaine cosmetique et/ou dermatologique
ATE216251T1 (de) Myrteextrakt enthaltendes haarpflegemittel, verfahren zur herstellung und verwendung insbesondere für eine antischuppenbehandlung
CA2335495A1 (en) Methods of exfoliation using n-acetyl glucosamine
WO2001039738A3 (de) Verwendung von flavonen und/oder isoflavonen aus pflanzenextrakten
HK1043326A1 (zh) 整容和治療的方法
BRPI0414734A (pt) introdução de cosméticos na pele
BG105924A (en) Composition for the treatment of psoriasis
WO2002054996A3 (en) Terazosin transdermal device and methods
WO2002024156A3 (de) Topische hautbehandlungsmittel mit arginase
ITRM930183A0 (it) Metodo di terapia, in particolare di terapia estetica, sostanze in gelo crema per esaltare l'effetto del trattamento ed apparecchiatura relativa per l'applicazione del metodo.
WO2004112743A3 (fr) Procede de soin cosmetique qui conjugue un effet mecanique, resultant d’un massage, a des effets biologiques en complement ou en relais

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties